Chesley Taft & Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,749
| Closed | -$873K | – | 263 |
|
|
2019
Q3 | $873K | Sell |
3,749
-718
| -16% | -$167K | 0.07% | 167 |
|
|
2019
Q2 | $1.04M | Sell |
4,467
-75
| -2% | -$17.3K | 0.08% | 153 |
|
|
2019
Q1 | $1.07M | Buy |
4,542
+135
| +3% | +$42.5K | 0.09% | 152 |
|
|
2018
Q4 | $1.33M | Buy |
4,407
+170
| +4% | +$54.3K | 0.13% | 132 |
|
|
2018
Q3 | $1.5M | Buy |
4,237
+45
| +1% | +$15.5K | 0.12% | 132 |
|
|
2018
Q2 | $1.22M | Sell |
4,192
-290
| -6% | -$81.5K | 0.1% | 153 |
|
|
2018
Q1 | $1.23M | Buy |
4,482
+100
| +2% | +$31K | 0.11% | 149 |
|
|
2017
Q4 | $1.4M | Buy |
4,382
+125
| +3% | +$40.1K | 0.12% | 147 |
|
|
2017
Q3 | $1.33M | Sell |
4,257
-125
| -3% | -$37K | 0.12% | 149 |
|
|
2017
Q2 | $1.19M | Buy |
4,382
+125
| +3% | +$33.1K | 0.11% | 159 |
|
|
2017
Q1 | $1.16M | Sell |
4,257
-25
| -0.6% | -$7.07K | 0.11% | 159 |
|
|
2016
Q4 | $1.21M | Sell |
4,282
-2,130
| -33% | -$631K | 0.12% | 140 |
|
|
2016
Q3 | $2.01M | Sell |
6,412
-215
| -3% | -$63.7K | 0.2% | 99 |
|
|
2016
Q2 | $1.6M | Buy |
6,627
+65
| +1% | +$17.1K | 0.16% | 115 |
|
|
2016
Q1 | $1.71M | Buy |
6,562
+230
| +4% | +$60.8K | 0.18% | 108 |
|
|
2015
Q4 | $1.94M | Sell |
6,332
-360
| -5% | -$103K | 0.2% | 105 |
|
|
2015
Q3 | $1.95M | Buy |
6,692
+6,042
| +930% | +$2M | 0.21% | 97 |
|
|
2015
Q2 | $263K | Hold |
650
| – | – | 0.03% | 209 |
|
|
2015
Q1 | $274K | Sell |
650
-9
| -1% | -$3.55K | 0.03% | 212 |
|
|
2014
Q4 | $224K | Hold |
659
| – | – | 0.02% | 229 |
|
|
2014
Q3 | $218K | Hold |
659
| – | – | 0.02% | 232 |
|
|
2014
Q2 | $208K | Buy |
+659
| New | +$198K | 0.02% | 238 |
|
Other funds holding BIIB
